Karen Addington, chief executive of Juvenile Diabetes Research Foundation, who funded the research said the study provided "proof of principle" of an artificial pancreas.
The foundation that guards his legacy has said in a statement there is "no proof whatsoever that suggests Pablo Neruda died of causes other than cancer".
There was no proof it would help (trials are under way at Stanford, partly sponsored by the SMA Foundation), but it had been safely used before on kids with sickle-cell anemia.